Pulmonx (LUNG) Return on Sales (2019 - 2025)

Pulmonx (LUNG) has 7 years of Return on Sales data on file, last reported at 0.01% in Q3 2025.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.01% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.01% (changed 0.0% YoY) and the FY2024 annual result came in at 0.01%, changed 0.0% from the prior year.
• Return on Sales slipped to 0.01% in Q3 2025 per LUNG's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Sales topped out at 0.01% in Q4 2024 and bottomed at 0.01% in Q1 2022.
• The 5-year median for Return on Sales is 0.01% (2023), against an average of 0.01%.
• Peak annual rise in Return on Sales reached 2 bps in 2021, while the deepest fall reached 1 bps in 2021.
• Tracing LUNG's Return on Sales over 5 years: stood at 0.01% in 2021, then rose by 2 bps to 0.01% in 2022, then grew by 22 bps to 0.01% in 2023, then climbed by 23 bps to 0.01% in 2024, then retreated by 17 bps to 0.01% in 2025.
• Per Business Quant, the three latest LUNG Return on Sales figures stand at 0.01% (Q3 2025), 0.01% (Q2 2025), and 0.01% (Q1 2025).

Peer Comparison